FK506/Rapamycin-inducible Adenovirus Vector Construction Service

Rapamycin-inducible adenovirus vectors have been shown to regulate target gene transcription effectively in cell culture and in animals. Based on state-of-the-art adenovirus vectors technology platform and experienced team of experts, Creative Biolabs offers comprehensive rapamycin-inducible adenoviral vector construction services to achieve controlled expression of the gene.

Introduction of FK506/Rapamycin-inducible Expression System

Temporal and spatial control of gene expression is a fundamental tool for regulated protein expression for basic, pharmaceutical and clinical research. Several systems for controlling gene expression have been developed and the latest inducible gene expression system is the rapamycin-based dimerization. Rapamycin is a small molecule natural product that mediates the formation of heterodimers between the immunophilin FK506 binding protein (FKBP) and the lipid kinase homolog FRAP. In this system, the transcriptional transactivation domain is provided by the p65 subunit of the NFκB p65 protein, which is fused to the rapamycin-binding domain of FRAP. The DNA-binding domain, termed ZFHD1, is a composite zinc finger homeodomain chimeric protein with DNA recognition specificity fused to a series of three repeats of the FKBP. These two proteins dimerize in the presence of rapamycin to form a functional transactivator which binds an inducible promoter containing ZFHDI binding sites upstream of an hCMV or other minimal promoters to regulate the expression of target genes.

Construction of FK506/Rapamycin-inducible Adenoviral Vectors

Rapamycin-inducible system has the potential to achieve tightly controlled gene regulation by expressing the transactivating and DNA-binding domains of a transcription factor as two separate proteins, each having a unique, highly specific rapamycin-binding domain, such that they dimerize to activate gene expression in the presence of rapamycin. This regulatable system can be integrated into adenoviral vectors to construct rapamycin-inducible adenoviral vectors to achieve controlled expression of the gene. In rapamycin-inducible adenoviral vectors, target genes and transcription factor components are delivered on isolated plasmids or on separate adenoviral vectors in vivo. Studies have shown that rapamycin-inducible adenoviral vectors are effective in controlling transgene expression in mice and non-human primates. One of the limitations of this approach is the growth inhibitory and immunosuppressive activity of rapamycin which is due to the inhibition of endogenous FRAP activity. This limitation can be overcome by developing nonimmunosuppressive analogs of rapamycin or modifying the FRAP sequence.

Figure 1. Schematic representation of adenoviral vector generations.¹

Why Choose an Inducible System for Your Gene Delivery?

Standard adenovirus vectors are powerful tools for high-efficiency transduction. However, their constitutive nature can be a limitation when studying:

• Toxic or growth-suppressive genes: Constitutive expression of pro-apoptotic or cell-cycle-arresting genes can prevent the expansion of transduced cells needed for analysis.
• Developmental or differentiation processes: Timing is critical. An inducible system allows you to initiate gene expression at a specific stage of cell differentiation.
• In vivo preclinical models: Sustained expression of certain transgenes may lead to immune responses or off-target effects. A system that can be switched on only when needed provides a clearer window into therapeutic efficacy and safety.
• Essential genes for cell viability: Inducible systems allow you to maintain a "gene-off" state during cell line generation and then activate the gene for functional studies.

Service

With world-class expertise of viral vector technology, Creative Biolabs provides high-quality and one-stop rapamycin-inducible adenoviral vector design and construction services to meet the demand in basic research and preclinical applications. Compared to traditional adenoviral vectors, our rapamycin-inducible adenoviral vectors exhibit the following advantages:

• The tightly regulated expression that allows for strict temporal control of adenovirus production.
• The modified FRAP sequence allowed us to induce gene expression with nonimmunosuppressive rapamycin analogs.
• This regulatory system enables long-term control of transgene expression in target cells.

In addition to the above services, Creative Biolabs also offers other regulated adenoviral vector construction services, including but not limited to the following:

• Radiation-induced Adenovirus Vector Construction
• Hypoxia-inducible Adenovirus Vector Construction
• Heat-induced Adenovirus Vector Construction
• Tetracycline-inducible Adenovirus Vector Construction

Our Service Workflow

We provide a fully integrated, end-to-end service pipeline:

1. Step 1: Project Consultation & Experimental Design

   We collaborate closely with clients to define:

   • Target gene and application
   • Expression control requirements
   • Induction kinetics
   • Vector backbone selection

2. Step 2: Vector Engineering & Construct Design

   Our design:

   • FKBP-fused DNA-binding domain
   • FRAP-fused transcription activation domain
   • Inducible promoter
   • Optimized gene cassette

   We ensure:

   • Minimal background expression
   • Maximum induction efficiency

3. Step 3: Adenovirus Construction & Packaging

   Using advanced adenoviral systems:

   • E1/E3-deleted backbone for safety
   • High-efficiency HEK293 packaging system
   • High-titer viral production

   Typical output:

   • ≥10¹⁰–10¹² viral particles
   • High infectivity across multiple cell types

4. Step 4: Functional Validation

   We perform rigorous validation:

   • Induction efficiency testing
   • Dose-response analysis
   • Time-course expression profiling
   • Western blot / qPCR validation

5. Step 5: Quality Control & Delivery

   Each project includes:

   • Viral titer determination
   • Sterility testing
   • Sequence verification
   • Functional assay reports

Why Choose Creative Biolabs?

Applications in Gene Research

I. Toxic Protein Expression

If your protein of interest is lethal to the packaging cells, constitutive expression makes viral production impossible. Our inducible system keeps the gene "Off" during the manufacturing phase and "On" only during the experimental phase.

II. Precision Oncology & CAR-T Research

Regulate the expression of cytokines (IL-12, IL-15) or suicide genes within the tumor microenvironment to maximize therapeutic effect while minimizing systemic toxicity.

III. Functional Genomics & Disease Modeling

Precisely mimic the temporal onset of genetic diseases by triggering gene knockdown (via shRNA/miRNA) or overexpression at specific developmental stages in animal models.

IV. Kinetic Studies

Study protein half-life, signaling pathways, and metabolic flux by pulsing gene expression with defined doses of Rapamycin.

What You'll Receive

Trusted by Researchers Worldwide

"We were looking for a tightly controlled inducible system to regulate cytokine expression in engineered immune cells. Creative Biolabs delivered a rapamycin-inducible adenoviral vector with remarkably low background expression and strong induction efficiency. The system worked exactly as designed, and their validation data was highly convincing.
Their team also provided valuable optimization suggestions for our experimental setup, which significantly accelerated our project timeline. We will definitely collaborate again for future vector engineering projects."

— Senior Scientist, Immuno-Oncology Biotech Company (USA)

"Our project required precise temporal control of gene expression in a complex in vivo model. Creative Biolabs not only constructed a robust FK506-inducible adenoviral system but also helped us fine-tune induction conditions for optimal performance.
The vector showed excellent dose-dependent responsiveness to rapamycin, and the turnaround time was faster than expected. Their communication was clear and professional throughout the entire process."

— Principal Investigator, Academic Research Lab (Europe)

"We partnered with Creative Biolabs to develop a drug-inducible expression system for preclinical studies. The final adenoviral vectors demonstrated consistent performance across multiple cell types and excellent reproducibility.
What stood out most was their ability to customize the system based on our specific needs and provide comprehensive QC and functional validation data. This level of detail gave us high confidence moving into downstream studies."

— Director of Translational Research, Pharmaceutical Company (Asia)

Frequently Asked Questions (FAQ)

Partner with Creative Biolabs

No matter what stage, scope or scale of your adenovirus vector project, we can provide you with customized solutions to meet any of your delivery needs. For more detailed information, please feel free to contact us or directly send us a quote.

Reference

1. Murala M S T, Gairola V, Sayedahmed E E, et al. Next-generation adenoviral vector-based vaccines for severe acute respiratory syndrome coronavirus-2. Vaccines, 2025, 13(4): 406. https://doi.org/10.3390/vaccines13040406 Distributed under Open Access license CC BY 4.0, without modification.